Related references
Note: Only part of the references are listed.Dendritic Cells Revisited
Mar Cabeza-Cabrerizo et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens
Johnathan Canton et al.
NATURE IMMUNOLOGY (2021)
Single-cell analyses reveal the clonal and molecular aetiology of Flt3L-induced emergency dendritic cell development
Dawn S. Lin et al.
NATURE CELL BIOLOGY (2021)
A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes
Koichi Murakami et al.
NATURE IMMUNOLOGY (2021)
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Johanna Bodder et al.
FRONTIERS IN IMMUNOLOGY (2021)
The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake
Alvaro de Mingo Pulido et al.
IMMUNITY (2021)
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
Francisco J. Cueto et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy
Francisco J. Cueto et al.
CANCERS (2021)
Type 1 conventional dendritic cell fate and function are controlled by DC-SCRIPT
Shengbo Zhang et al.
SCIENCE IMMUNOLOGY (2021)
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity
Evangelos Giampazolias et al.
CELL (2021)
NLRP3 inflammasomes that induce antitumor immunity
Dania Zhivaki et al.
TRENDS IN IMMUNOLOGY (2021)
Genetic models of human and mouse dendritic cell development and function
David A. Anderson et al.
NATURE REVIEWS IMMUNOLOGY (2021)
STAT3 Inhibits CD103+ cDC1 Vaccine Efficacy in Murine Breast Cancer
Taylor T. Chrisikos et al.
CANCERS (2020)
Engineered niches support the development of human dendritic cells in humanized mice
Giorgio Anselmi et al.
NATURE COMMUNICATIONS (2020)
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103(+) conventional dendritic cells
Yifan Zhou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-gamma, CXCL9 and CXCL10
Cristina Bergamaschi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A conserved dendritic-cell regulatory program limits antitumour immunity
Barbara Maier et al.
NATURE (2020)
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
Junyun Lai et al.
NATURE IMMUNOLOGY (2020)
Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells
Megan K. Ruhland et al.
CANCER CELL (2020)
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
Niels Vandamme et al.
CANCER RESEARCH (2020)
Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans
Urszula Cytlak et al.
IMMUNITY (2020)
High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity
Sunkyung Kim et al.
IMMUNITY (2020)
Transcriptional Networks Driving Dendritic Cell Differentiation and Function
Stephen L. Nutt et al.
IMMUNITY (2020)
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Jeffrey H. Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Insights from Patients with Dendritic Cell Immunodeficiency
Venetia Bigley et al.
MOLECULAR IMMUNOLOGY (2020)
cDC1 prime and are licensed by CD4+T cells to induce anti-tumour immunity
Stephen T. Ferris et al.
NATURE (2020)
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
Qi Peng et al.
NATURE COMMUNICATIONS (2020)
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s
Takaaki Oba et al.
NATURE COMMUNICATIONS (2020)
Inflammasomes within Hyperactive Murine Dendritic Cells Stimulate Long-Lived T Cell-Mediated Anti-tumor Immunity
Dania Zhivaki et al.
CELL REPORTS (2020)
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer
Soyoung A. Oh et al.
NATURE CANCER (2020)
Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+dendritic cells to activate naive and memory WT1-specific CD8+T cells
Frances E. Pearson et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice
Daisuke Kurotaki et al.
BLOOD (2019)
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes
Moritz Rapp et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
Stefanie K. Wculek et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
CUT&Tag for efficient epigenomic profiling of small samples and single cells
Hatice S. Kaya-Okur et al.
NATURE COMMUNICATIONS (2019)
Trial watch: dendritic cell vaccination for cancer immunotherapy
Jenny Sprooten et al.
ONCOIMMUNOLOGY (2019)
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification
Vivek Durai et al.
NATURE IMMUNOLOGY (2019)
An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development
Prachi Bagadia et al.
NATURE IMMUNOLOGY (2019)
Transcription Factor PU.1 Promotes Conventional Dendritic Cell Identity and Function via Induction of Transcriptional Regulator DC-SCRIPT
Michael Chopin et al.
IMMUNITY (2019)
Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Jean-Charles Cancel et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dendritic cell subsets
Christophe Macri et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Activation of human CD141(+) and CD1c(+) dendritic cells in vivo with combined TLR3 and TLR7/8 ligation
Frances E. Pearson et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation
Venetia Bigley et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression
Heng Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Paula Michea et al.
NATURE IMMUNOLOGY (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
Melissa A. Meyer et al.
NATURE COMMUNICATIONS (2018)
Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells
Margaret E. Kirkling et al.
CELL REPORTS (2018)
Transcription factor Etv6 regulates functional differentiation of cross-presenting classical dendritic cells
Colleen M. Lau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity
Sreekumar Balan et al.
CELL REPORTS (2018)
Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming
Alfonso R. Sanchez-Paulete et al.
CANCER RESEARCH (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
WDFY4 is required for cross-presentation in response to viral and tumor antigens
Derek J. Theisen et al.
SCIENCE (2018)
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Boettcher et al.
TRENDS IN CANCER (2018)
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells
Fabio F. Rosa et al.
SCIENCE IMMUNOLOGY (2018)
Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life
Tomer Granot et al.
IMMUNITY (2017)
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Abhishek D. Garg et al.
IMMUNOLOGICAL REVIEWS (2017)
Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
Andres Alloatti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Mapping the human DC lineage through the integration of high-dimensional techniques
Peter See et al.
SCIENCE (2017)
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Alexandra-Chloe Villani et al.
SCIENCE (2017)
Dendritic Cell Lineage Potential in Human Early Hematopoietic Progenitors
Julie Helft et al.
CELL REPORTS (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines
Mansi Saxena et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Lineage specification of human dendritic cells is marked by IRF8 expression in hematopoietic stem cells and multipotent progenitors
Jaeyop Lee et al.
NATURE IMMUNOLOGY (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells
Kristian M. Hargadon et al.
IMMUNOLOGY AND CELL BIOLOGY (2016)
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sanchez-Paulete et al.
CANCER DISCOVERY (2016)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming
Maria E. Rodriguez-Ruiz et al.
CANCER RESEARCH (2016)
Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1+ Dendritic Cells
Salvador Iborra et al.
IMMUNITY (2016)
IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively
Dorine Sichien et al.
IMMUNITY (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2
Charlotte L. Scott et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells
Nicole M. Kretzer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Transcription factor Zeb2 regulates commitment to plasmacytoid dendritic cell and monocyte fate
Xiaodi Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow
Jaeyop Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Human blood CD1c dendritic cells stimulate IL-12-independent IFN-γ responses and have a strikingly low inflammatory profile
Adel Benlahrech et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Batf3 maintains autoactivation of Irf8 for commitment of a CD8α+ conventional DC clonogenic progenitor
Gary E. Grajales-Reyes et al.
NATURE IMMUNOLOGY (2015)
Identification of cDC1-and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow
Andreas Schlitzer et al.
NATURE IMMUNOLOGY (2015)
Vaccine adjuvant uses of poly-IC and derivatives
Karen Ao Martins et al.
EXPERT REVIEW OF VACCINES (2015)
Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow
Christian Thomas Mayer et al.
BLOOD (2014)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
A Reporter Mouse Reveals Lineage-Specific and Heterogeneous Expression of IRF8 during Lymphoid and Myeloid Cell Differentiation
Hongsheng Wang et al.
JOURNAL OF IMMUNOLOGY (2014)
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Martin Guilliams et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses
Giulia Nizzoli et al.
BLOOD (2013)
Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness
Caroline Hemont et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Diverse and heritable lineage imprinting of early haematopoietic progenitors
Shalin H. Naik et al.
NATURE (2013)
PU.1 Level-Directed Chromatin Structure Remodeling at the Irf8 Gene Drives Dendritic Cell Commitment
Joerg Schoenheit et al.
CELL REPORTS (2013)
The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34+ stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin
A. I. Proietto et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments
Jian-Guo Zhang et al.
IMMUNITY (2012)
Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages
Ansuman T. Satpathy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Compensatory dendritic cell development mediated by BATF-IRF interactions
Roxane Tussiwand et al.
NATURE (2012)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
NFIL3/E4BP4 is a key transcription factor for CD8α+ dendritic cell development
Masaki Kashiwada et al.
BLOOD (2011)
Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages
Jacob T. Jackson et al.
EMBO JOURNAL (2011)
CD8α+ Dendritic Cells Are the Critical Source of Interleukin-12 that Controls Acute Infection by Toxoplasma gondii Tachyzoites
Mona Mashayekhi et al.
IMMUNITY (2011)
IRF8 Mutations and Human Dendritic-Cell Immunodeficiency
Sophie Hambleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Transcription Factor PU.1 Controls Dendritic Cell Development and Flt3 Cytokine Receptor Expression in a Dose-Dependent Manner
Sebastian Carotta et al.
IMMUNITY (2010)
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells
Karine Crozat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Sarah L. Jongbloed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Resident and Monocyte-Derived Dendritic Cells Become Dominant IL-12 Producers under Different Conditions and Signaling Pathways
Yifan Zhan et al.
JOURNAL OF IMMUNOLOGY (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
David Sancho et al.
NATURE (2009)
The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development
Duncan M. Gascoyne et al.
NATURE IMMUNOLOGY (2009)
In Vivo Analysis of Dendritic Cell Development and Homeostasis
Kang Liu et al.
SCIENCE (2009)
The receptor tyrosine kinase FIt3 is required for dendritic cell development in peripheral lymphoid tissues
Claudia Waskow et al.
NATURE IMMUNOLOGY (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse
Prafullakumar Tailor et al.
BLOOD (2008)
Identification of clonogenic common Flt3+ M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow
Nobuyuki Onai et al.
NATURE IMMUNOLOGY (2007)
Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo
Shalin H. Naik et al.
NATURE IMMUNOLOGY (2007)
Dendritic cells prime natural killer cells by trans-presenting interleukin 15
Mathias Lucas et al.
IMMUNITY (2007)
Identification and characterization of DC-SCRIPT, a novel dendritic cell-expressed member of the zinc finger family of transcriptional regulators
V Triantis et al.
JOURNAL OF IMMUNOLOGY (2006)
Cutting edge:: Generation of splenic CD8+ and CD8- dendritic cell equivalents in fms-like tyrosine kinase 3 ligand bone marrow cultures
SH Naik et al.
JOURNAL OF IMMUNOLOGY (2005)
NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs
C Borg et al.
BLOOD (2004)
The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3
A D'Amico et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Transcriptional profiling identifies Id2 function in dendritic cell development
C Hacker et al.
NATURE IMMUNOLOGY (2003)
Conditional expression of murine Flt3 ligand leads to expansion of multiple dendritic cell subsets in peripheral blood and tissues of transgenic mice
DJ Manfra et al.
JOURNAL OF IMMUNOLOGY (2003)
ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8α+ dendritic cells
G Schiavoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood
A Dzionek et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
